(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 9.83% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.23%.
Iradimed's revenue in 2026 is $86,282,363.On average, 5 Wall Street analysts forecast IRMD's revenue for 2026 to be $1,190,432,917, with the lowest IRMD revenue forecast at $1,142,496,536, and the highest IRMD revenue forecast at $1,226,787,869. On average, 5 Wall Street analysts forecast IRMD's revenue for 2027 to be $1,315,629,962, with the lowest IRMD revenue forecast at $1,252,737,430, and the highest IRMD revenue forecast at $1,366,378,611.
In 2028, IRMD is forecast to generate $1,468,131,570 in revenue, with the lowest revenue forecast at $1,410,607,912 and the highest revenue forecast at $1,511,338,228.